2,117
Views
32
CrossRef citations to date
0
Altmetric
Original Article

Docetaxel-induced neuropathy: A pharmacogenetic case-control study of 150 women with early-stage breast cancer

, , , &
Pages 535-542 | Received 02 Mar 2014, Accepted 17 Sep 2014, Published online: 22 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Elizabeth Andersen Hammond, Marshall Pitz, Pascal Lambert & Barbara Shay. (2019) Quantitative sensory profiles of upper extremity chemotherapy induced peripheral neuropathy: Are there differences in sensory profiles for neuropathic versus nociceptive pain?. Canadian Journal of Pain 3:1, pages 169-177.
Read now
Ingolf Cascorbi & Anneke Nina Werk. (2017) Advances and challenges in hereditary cancer pharmacogenetics. Expert Opinion on Drug Metabolism & Toxicology 13:1, pages 73-82.
Read now
Sonam Tulsyan, Rama Devi Mittal & Balraj Mittal. (2016) The effect of ABCB1 polymorphisms on the outcome of breast cancer treatment. Pharmacogenomics and Personalized Medicine 9, pages 47-58.
Read now
Sylvia Chen, Natalia Sutiman, Clara Zhenxian Zhang, Yingnan Yu, Shirley Lam, Chiea Chuen Khor & Balram Chowbay. (2016) Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review. Drug Metabolism Reviews 48:4, pages 502-540.
Read now

Articles from other publishers (28)

Laurence McEvoy, Joanne Cliff, Daniel F Carr, Andrea Jorgensen, Rosemary Lord & Munir Pirmohamed. (2023) CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study. Frontiers in Pharmacology 14.
Crossref
Alberto Guijosa, Ana Freyria, Jose Rodrigo Espinosa‐Fernandez, Francisco J. Estrada‐Mena, Ana Sofía Armenta‐Quiroga, Maria Fernanda Ortega‐Treviño, Rodrigo Catalán, Bani Antonio‐Aguirre, Cynthia Villarreal‐Garza & Andric C. Perez‐Ortiz. (2022) Pharmacogenetics of taxane‐induced neurotoxicity in breast cancer: Systematic review and meta‐analysis. Clinical and Translational Science 15:10, pages 2403-2436.
Crossref
Jialin Gu, Miao Hu, Zhancheng Gu, Jialin Yu, Yi Ji, Lingchang Li, Canhong Hu, Guoli Wei & Jiege Huo. (2022) Bibliometric Analysis Reveals a 20-Year Research Trend for Chemotherapy-Induced Peripheral Neuropathy. Frontiers in Neurology 12.
Crossref
Mingrui Yan, Xiaoyu Fan, Hongyanhua Si, Xiaoyu Wang, Zhe Wang, Zhen Wang, Xin Lv, Hang Yin, Yanyan Jia, Lili Jiang, Yangliu Xia & Yong Liu. (2022) Association between gene polymorphism and adverse effects in cancer patients receiving docetaxel treatment: a meta-analysis. Cancer Chemotherapy and Pharmacology 89:2, pages 173-181.
Crossref
Eleonora Pozzi & Paola Alberti. 2022. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development 95 140 .
Jamie Burgess, Maryam Ferdousi, David Gosal, Cheng Boon, Kohei Matsumoto, Anne Marshall, Tony Mak, Andrew Marshall, Bernhard Frank, Rayaz A. Malik & Uazman Alam. (2021) Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment. Oncology and Therapy 9:2, pages 385-450.
Crossref
Jialin Gu, Hong Lu, Chen Chen, Zhancheng Gu, Miao Hu, Ling Liu, Jialin Yu, Guoli Wei & Jiege Huo. (2021) Diabetes mellitus as a risk factor for chemotherapy-induced peripheral neuropathy: a meta-analysis. Supportive Care in Cancer 29:12, pages 7461-7469.
Crossref
Matthew R. Trendowski, Christine M. Lusk, Julie J. Ruterbusch, Randell Seaton, Michael S. Simon, Mark K. Greenwald, Felicity W. K. Harper, Jennifer L. Beebe‐Dimmer & Ann G. Schwartz. (2021) Chemotherapy‐induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes. Cancer Medicine 10:22, pages 8151-8161.
Crossref
Daniel L. Hertz, Cindy Tofthagen & Sara Faithfull. 2021. Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy. Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy 19 51 .
Qingyang Xiao, Yitian Zhou & Volker M Lauschke. (2020) Impact of variants in ATP-binding cassette transporters on breast cancer treatment. Pharmacogenomics 21:18, pages 1299-1310.
Crossref
Luiz Carlos da Costa Junior, Clarissa Lourenço de Castro, Daniely Regina Freitas-Alves, Rosane Vianna-Jorge & Paulo Caleb Júnior Lima Santos. (2020) ABCB1 and ERCC1 gene polymorphisms are associated with nephro- and hepatotoxicity to carboplatin/paclitaxel-based chemotherapy in patients with gynecologic cancers. European Journal of Clinical Pharmacology 76:10, pages 1401-1408.
Crossref
Marie-Louise Mallet, Marios Hadjivassiliou, Ptolemaios Georgios Sarrigiannis & Panagiotis Zis. (2020) The Role of Oxidative Stress in Peripheral Neuropathy. Journal of Molecular Neuroscience 70:7, pages 1009-1017.
Crossref
Zeina N. Al-Mahayri, George P. Patrinos & Bassam R. Ali. (2020) Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy. Frontiers in Pharmacology 11.
Crossref
Nathan P. Staff, Jill C. Fehrenbacher, Martial Caillaud, M. Imad Damaj, Rosalind A. Segal & Sandra Rieger. (2020) Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems. Experimental Neurology 324, pages 113121.
Crossref
Elizabeth Andersen Hammond, Marshall Pitz & Barbara Shay. (2019) Neuropathic Pain in Taxane-Induced Peripheral Neuropathy: Evidence for Exercise in Treatment. Neurorehabilitation and Neural Repair 33:10, pages 792-799.
Crossref
Alexandre Chan, Daniel L. Hertz, Manuel Morales, Elizabeth J. Adams, Sharon Gordon, Chia Jie Tan, Nathan P. Staff, Jayesh Kamath, Jeong Oh, Shivani Shinde, Doreen Pon, Niharkia Dixit, James D’Olimpio, Cristina Dumitrescu, Margherita Gobbo, Kord Kober, Samantha Mayo, Linda Pang, Ishwaria Subbiah, Andreas S. Beutler, Katherine B. Peters, Charles Loprinzi & Maryam B. Lustberg. (2019) Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview. Supportive Care in Cancer 27:10, pages 3729-3737.
Crossref
Kirsten A. Nyrop, Allison M. Deal, Kathryn E. Reeder‐Hayes, Shlomit S. Shachar, Bryce B. Reeve, Ethan Basch, Seul Ki Choi, Jordan T. Lee, William A. Wood, Carey K. Anders, Lisa A. Carey, Elizabeth C. Dees, Trevor A. Jolly, Gretchen G. Kimmick, Meghan S. Karuturi, Raquel E. Reinbolt, JoEllen C. Speca & Hyman B. Muss. (2019) Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practice. Cancer 125:17, pages 2945-2954.
Crossref
Kirsten A. Nyrop, Allison M. Deal, Shlomit S. Shachar, Ethan Basch, Bryce B. Reeve, Seul Ki Choi, Jordan T. Lee, William A. Wood, Carey K. Anders, Lisa A. Carey, Elizabeth C. Dees, Trevor A. Jolly, Katherine E. Reeder-Hayes, Gretchen G. Kimmick, Meghan S. Karuturi, Raquel E. Reinbolt, JoEllen C. Speca & Hyman B. Muss. (2019) Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer. The Oncologist 24:6, pages 762-771.
Crossref
A.G.J. van Rossum, M. Kok, E. van Werkhoven, M. Opdam, I.A.M. Mandjes, A.E. van Leeuwen – Stok, H. van Tinteren, A.L.T. Imholz, J.E.A. Portielje, M.M.E.M. Bos, A. van Bochove, J. Wesseling, E.J. Rutgers, S.C. Linn & H.M. Oosterkamp. (2018) Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04). European Journal of Cancer 102, pages 40-48.
Crossref
Hanna Bandos, Joy Melnikow, Donna R. Rivera, Sandra M. Swain, Keren Sturtz, Louis Fehrenbacher, James L. WadeIIIIII, Adam M. Brufsky, Thomas B. Julian, Richard G. Margolese, Edward C. McCarron & Patricia A. Ganz. (2018) Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30. JNCI: Journal of the National Cancer Institute 110:2.
Crossref
Donna R. Rivera, Patricia A. Ganz, Meghan S. Weyrich, Hanna Bandos & Joy Melnikow. (2018) Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review. JNCI: Journal of the National Cancer Institute 110:2.
Crossref
Annelot G.J. van Rossum, Marleen Kok, Danielle McCool, Mark Opdam, Nienke C. Miltenburg, Ingrid A.M. Mandjes, Elise van Leeuwen-Stok, Alex L.T. Imholz, Johanneke E.A. Portielje, Monique M.E.M. Bos, Aart van Bochove, Erik van Werkhoven, Marjanka K. Schmidt, Hendrika M. Oosterkamp & Sabine C. Linn. (2017) Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy. Oncotarget 8:69, pages 113531-113542.
Crossref
J. Cliff, A.L. Jorgensen, R. Lord, F. Azam, L. Cossar, D.F. Carr & M. Pirmohamed. (2017) The molecular genetics of chemotherapy–induced peripheral neuropathy: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 120, pages 127-140.
Crossref
S.B. Park, J.B. Kwok, R. Asher, C.K. Lee, P. Beale, F. Selle & M. Friedlander. (2017) Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trial. Annals of Oncology 28:11, pages 2733-2740.
Crossref
M. Eileen Dolan, Omar El Charif, Heather E. Wheeler, Eric R. Gamazon, Shirin Ardeshir-Rouhani-Fard, Patrick Monahan, Darren R. Feldman, Robert J. Hamilton, David J. Vaughn, Clair J. Beard, Chunkit Fung, Jeri Kim, Sophie D. Fossa, Daniel L Hertz, Taisei Mushiroda, Michiaki Kubo, Lawrence H. Einhorn, Nancy J. Cox & Lois B. Travis. (2017) Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer. Clinical Cancer Research 23:19, pages 5757-5768.
Crossref
Christine Miaskowski, Judy Mastick, Steven M. Paul, Kimberly Topp, Betty Smoot, Gary Abrams, Lee-May Chen, Kord M. Kober, Yvette P. Conley, Margaret Chesney, Kay Bolla, Grace Mausisa, Melissa Mazor, Melisa Wong, Mark Schumacher & Jon D. Levine. (2017) Chemotherapy-Induced Neuropathy in Cancer Survivors. Journal of Pain and Symptom Management 54:2, pages 204-218.e2.
Crossref
Andreas A. Argyriou, Jordi Bruna, Armando A. Genazzani & Guido Cavaletti. (2017) Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics. Nature Reviews Neurology 13:8, pages 492-504.
Crossref
Daniel L. Hertz, Kouros Owzar, Sherrie Lessans, Claudia Wing, Chen Jiang, William Kevin Kelly, Jai Patel, Susan Halabi, Yoichi Furukawa, Heather E. Wheeler, Alexander B. Sibley, Cameron Lassiter, Lois Weisman, Dorothy Watson, Stefanie D. Krens, Flora Mulkey, Cynthia L. Renn, Eric J. Small, Phillip G. Febbo, Ivo Shterev, Deanna L. Kroetz, Paula N. Friedman, John F. Mahoney, Michael A. Carducci, Michael J. Kelley, Yusuke Nakamura, Michiaki Kubo, Susan G. Dorsey, M. Eileen Dolan, Michael J. Morris, Mark J. Ratain & Howard L. McLeod. (2016) Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy . Clinical Cancer Research 22:19, pages 4890-4900.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.